In the course of a study of various prognostic factors in malignant lung conditions, we confirmed the findings of Jakoubkova and Majsky (1965) that there appears to be no increase in the incidence of lung cancer within any particular blood group. However, we have observed a distinct association between blood group and survival following surgery.
Eighty-six patients who had resection of lung cancers between 1978 and 1983 (62 squamous cell carcinomas, 20 adenocarcinomas and 4 small cell carcinomas) were studied. These patients had no evidence of metastatic spread at the time of operation. The overall frequency of the ABO blood groups was comparable to that of the normal population (Race & Sanger, 1975 ) (A 32%, B 12%, AB 6%, 0 50%) and the distribution of histological types was similar within each blood group. Using the Log Rank test we found that those patients who were blood group B or AB had a significantly shorter survival following operation than patients within other blood groups (P= 0.0017) ( Table I ). The median survival of patients with blood group AB was 14 months; of patients with blood group B, 24 months; of patients with blood group A greater than 48 months and of those with blood group 0 greater than 60 months. The median follow up was 41 months. Median survival in excess of 60 months initially seemed surprisingly good but these patients were a highly selected group; all had limited disease 
